CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for China Development Bank Capital Co., Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

China Development Bank Capital Co., Ltd.
No.18 Fuxingmennei Street
Xicheng District
Beijing, 100037  China

This is a Subsidiary, click here for the Parent Company

Business Summary
China Development Bank Capital Co., Ltd. ("CDB Capital") is a highly integrated and wholly owned subsidiary of China Development Bank Corporation. CDB Capital plays an important role in supporting companies that are strategically important to China's investment and development strategies through fund management, private equity and mezzanine investments. The Company also provides asset management services and manages bilateral and multilateral funds to support China's economic and foreign affair initiatives.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-----Yes-

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
--Yes----


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, January 10, 2023